ArticleEClinicalMedicine2021

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.

Pablo Tebas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.